CX157

CX157

Systematic (IUPAC) name
3-fluoro-7-(2,2,2-trifluoroethoxy)phenoxathiine 10,10-dioxide
Clinical data
Legal status	Uncontrolled
Routes of administration	Oral
Identifiers
ATC code	none
PubChem	CID: 18687754
ChemSpider	13701383 Y
Chemical data
Formula	C14H8F4O4S
Molecular mass	348.27 g/mol
SMILES FC(F)(F)COc2cc3Oc1cc(F)ccc1S(=O)(=O)c3cc2
InChI InChI=1S/C14H8F4O4S/c15-8-1-3-12-10(5-8)22-11-6-9(21-7-14(16,17)18)2-4-13(11)23(12,19)20/h1-6H,7H2 Y Key:PDIMOTRDGUQMNY-UHFFFAOYSA-N Y
(verify)

CX157 (proposed trade name TriRima, formerly Tyrima) is a selective and reversible inhibitor of MAO-A (RIMA). As of 2007 it was in phase II clinical trials for the treatment of depression. In 2013, it was discontinued for both depression and anxiety.[1]